Group items tagged

The South Korean pharmaceutical industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. An increase in insurance coverage, an ageing population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry in South Korea. Improved intellectual property rights, changing demographics and government support have contributed towards making the South Korean pharmaceutical industry attractive for MNCs.

South Korean retail sales grew at a CAGR of 4.35% during 2007-2012. The major channel groups comprise of general retailers, specialist retailers, value retailers and online retailers. General Retailers in South Korea was the largest channel group with hypermarkets, supermarkets and hard-discounters recording the highest sales among the various channels under the general retailers channel group.

2015 Global Retinoblastoma Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Retinoblastoma Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).